AURKA and neoplasm: Furthermore, Aur-A was overexpressed or amplified in hepatocellular carcinoma [19], laryngeal squamous cell carcinoma (LSCC) [20], esophageal squamous cell carcinoma [21], ovarian cancer [22], and neuroblastoma [23], contributing to tumor progression and poor prognosis.